Chloe Taft
(cover story)The article reports on the restructuring initiatives of Cagus Nerve Stimulation (VNS) therapy provider Cyberonics. To enhance its efficiency and reduce operating costs, the company launched a 15% reduction in staff headcount, cutting 90 people from its 600-employee workforce. It has ...
Cyberonics, Inc. (http://www.cyberonics.com ) was founded in 1987 to design,develop and market medical devices for the treatment of epilepsy and otherdebilitating disorders using a unique therapy, vagus nerve stimulation. VNStherapy is delivered by the Cyberonics NeuroCybernetic Prosthesis (NCP(...
or eliminate epileptic seizures, as described in U.S. Pat. No. 4,702,254 to Dr. Jacob Zabara, which is hereby incorporated in its entirety herein by reference in this specification. Electrical stimulation of the vagus nerve (hereinafter referred to as vagus nerve stimulation therapy or VNS) ...
VNS Therapy Depression Claim Rejected Over Randomization – CyberonicsPeter Fehrs
Cyberonics wins FDA approval for AspireHC for VNS therapyThe article reports on the approval by the U.S. Food and Drug Administration (FDA) of the AspireHC generator developed by Cyberonics for vagus nerve stimulation (VNS) therapy. According to president Dan Moore, the device is a continued...
Peter Fehrs
Peter FehrsJon Dobson
The article reports on a comprehensive process that was completed by Cyberonics with respect to an effort to identify a partner for the depression indication related to the Vagus Nerve Stimulation therapy system of the company...
Cyberonics caps 7-year effort with VNS depression approval.(Vagus Nerve Stimulation therapy system)JOHNSON, HOLLAND